AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG and its maternal health division, Lumara Health, is to bring to market therapies that provide clear benefits and improve patients' lives. In addition to continuing to pursue opportunities to make new advancements in patients' health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies.
Waltham, US
552 (est)
AMAG Pharmaceuticals was founded in 1981 and is headquartered in Waltham, US

AMAG Pharmaceuticals Locations

Waltham, US

AMAG Pharmaceuticals Metrics

AMAG Pharmaceuticals Summary

Market capitalization

$787 M

Closing share price

AMAG Pharmaceuticals's current market capitalization is $787 M.

AMAG Pharmaceuticals Financials

AMAG Pharmaceuticals's revenue is $418 M in FY, 2015 which is 236.28% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$80.9 M$124 M$418 M

Gross profit

$68.9 M$104 M$408 M

Operating income

$-7.59 M$-3.84 M$111 M

Operating expense total

$80.5 M$108 M$297 M

Net Income

$-9.6 M$136 M$32.8 M

Operating cash flow

$-19.3 M$92.3 M$109 M

    AMAG Pharmaceuticals Market Value History

    AMAG Pharmaceuticals News

    AMAG Pharmaceuticals Company Life

    You may also be interested in